Cargando…
Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma
Background. Survivin is an inhibitor of apoptosis protein involved in the regulation of cell proliferation that could be used as a marker for cancer diagnosis or prognosis. Our aim was to evaluate whether serum survivin levels influence the outcome of cisplatin-based chemotherapy in patients with ma...
Autores principales: | Goričar, Katja, Kovač, Viljem, Franko, Alenka, Dodič-Fikfak, Metoda, Dolžan, Vita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588029/ https://www.ncbi.nlm.nih.gov/pubmed/26451067 http://dx.doi.org/10.1155/2015/316739 |
Ejemplares similares
-
Serum Calretinin as a Biomarker in Malignant Mesothelioma
por: Zupanc, Cita, et al.
Publicado: (2021) -
The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma
por: Franko, Alenka, et al.
Publicado: (2018) -
Soluble Mesothelin-Related Peptides Levels in Patients with Malignant Mesothelioma
por: Franko, Alenka, et al.
Publicado: (2012) -
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
por: Kovac, Viljem, et al.
Publicado: (2015) -
NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases
por: Franko, Alenka, et al.
Publicado: (2020)